Asymchem’s Fully Automated Peptide Production Lines Set New Benchmarks as Large-Scale Capacity Continues to Grow
MORRISVILLE, N.C., November 12, 2024--To facilitate large-scale production of peptide drugs, Asymchem, a leading global pharmaceutical CDMO, has achieved fully automated manufacturing.